Assorted News from the Last Week: Drug combination sidesteps resistance in aggressive childhood neuroblastoma models. Study results suggest that apatinib plus IE may improve PFS
Assorted News from the Last Week: This edition of the CAC2 blog post provides a compassionate guide to embracing bereaved families during the holidays. Columbia
By CAC2 Staffer Bethany Lieberman As we close out 2025, typically a joyful time that recognizes dozens of religious, spiritual, andcultural holidays, the season can
Assorted News from the Last Week: The impact of focused federal initiatives on pediatric cancer research: continuous support for both CCDI and the STAR Act
Assorted News from the Last Week: CAC2 Supporting Organization Member Syndax Pharmaceuticals announced that the Food and Drug Administration approved revumenib, a menin inhibitor, for
When I first heard about the Coalition Against Childhood Cancer (CAC2), I remember thinking — this is what our community has been waiting for. A
Assorted News from the Last Week: This edition of the CAC2 blog post addresses how childhood cancer affects the academic success of school-aged siblings. Iopofosine-131
By CAC2 Staffer Bethany Lieberman This is the second blog in a two-part series. This post addresses how childhood cancer affects the academic success of
Assorted News from the Last Week: South African authorities have suspended eight pupils linked to a case of alleged bullying of a childhood cancer patient
Assorted News from the Last Week: U.S. policy changes mean Canadian children with cancer are losing access to clinical trials. Sensitisation, early detection: The lifeline
